{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T14:21:06Z","timestamp":1793715666949,"version":"4.6.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"National Audit of Breast Cancer in Older Patients"},{"name":"Healthcare Quality Improvement Partnership"},{"name":"NHS"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","valueinhealthjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.jval.2020.05.013","type":"journal-article","created":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T18:25:51Z","timestamp":1595960751000},"page":"1316-1323","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Costs of Early Invasive Breast Cancer in England Using National Patient-Level Data"],"prefix":"10.1016","volume":"23","author":[{"given":"Li","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Cromwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Dodwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kieran","family":"Horgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa Ruth","family":"Gannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jibby","family":"Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Pennington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Legood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"dos-Santos-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zia","family":"Sadique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jval.2020.05.013_bib1","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jval.2020.05.013_bib2","doi-asserted-by":"crossref","first-page":"g366","DOI":"10.1136\/bmj.g366","article-title":"Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial","volume":"348","author":"Miller","year":"2014","journal-title":"BMJ"},{"issue":"9972","key":"10.1016\/j.jval.2020.05.013_bib3","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0140-6736(14)62038-9","article-title":"Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2)","volume":"385","author":"Allemani","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jval.2020.05.013_bib4","series-title":"Division of Cancer Prevention and Control, Surveillance Program, Cancer Statistics Branch","year":"1973"},{"issue":"11","key":"10.1016\/j.jval.2020.05.013_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207993","article-title":"Global treatment costs of breast cancer by stage: a systematic review","volume":"13","author":"Sun","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jval.2020.05.013_bib6","series-title":"Saving Lives, Averting Costs","author":"Bomb","year":"2014"},{"issue":"5","key":"10.1016\/j.jval.2020.05.013_bib7","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/tbj.12447","article-title":"Predictors of health care use of women with breast cancer: a systematic review","volume":"21","author":"Lo-Fo-Wong","year":"2015","journal-title":"Breast Journal"},{"issue":"2","key":"10.1016\/j.jval.2020.05.013_bib8","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1017\/S0266462300012253","article-title":"The costs of treating breast cancer in the United Kingdom: implications for screening","volume":"14","author":"Wolstenholme","year":"1998","journal-title":"Int J Technol Assess Health Care"},{"key":"10.1016\/j.jval.2020.05.013_bib9","series-title":"Clinical Guideline (CG80): Early and Locally Advanced Breast Cancer: Diagnosis and Treatment","year":"2009"},{"key":"10.1016\/j.jval.2020.05.013_bib10","series-title":"Focussing on Inequalities: Variation in Breast Cancer Outcomes With Age and Deprivation","article-title":"The Second All Breast Cancer Report","year":"2011"},{"issue":"1","key":"10.1016\/j.jval.2020.05.013_bib11","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1470-2045(13)70546-1","article-title":"Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study","volume":"15","author":"De Angelis","year":"2014","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.jval.2020.05.013_bib12","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejso.2016.09.019","article-title":"National trends in immediate and delayed post-mastectomy reconstruction procedures in England: a seven-year population-based cohort study","volume":"43","author":"Mennie","year":"2017","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.jval.2020.05.013_bib13","series-title":"2018 Annual Report","article-title":"National Audit of Breast Cancer in Older Patients","year":"2018"},{"issue":"6","key":"10.1016\/j.jval.2020.05.013_bib18","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/aje\/kwq433","article-title":"Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries","volume":"173","author":"Quan","year":"2011","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jval.2020.05.013_bib19","series-title":"Social Value Judgements: Principles for the Development of NICE Guidance","year":"2008"},{"key":"10.1016\/j.jval.2020.05.013_bib20","series-title":"Clinical Guideline\u00a0(CG1): Guideline on Improving Outcomes in Breast Cancer","year":"2002"},{"key":"10.1016\/j.jval.2020.05.013_bib21","series-title":"Early and Locally Advanced Breast Cancer: Diagnosis and Treatment","year":"2009"},{"key":"10.1016\/j.jval.2020.05.013_bib22","series-title":"National Costing Report: Early and Locally Advanced Breast Cancer\/Advanced Breast Cancer","year":"2009"},{"issue":"1","key":"10.1016\/j.jval.2020.05.013_bib23","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10549-013-2422-4","article-title":"A\u00a0meta-regression analysis of the available data on adherence to adjuvant hormonal therapy in breast cancer: summarizing the data for clinicians","volume":"138","author":"Huiart","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.jval.2020.05.013_bib24","series-title":"NHS Reference Costs 2015 to 2016","year":"2016"},{"key":"10.1016\/j.jval.2020.05.013_bib25","series-title":"British National Formulary","year":"2018"},{"key":"10.1016\/j.jval.2020.05.013_bib26","series-title":"Unit Costs of Health and Social Care 2011","author":"Curtis","year":"2011"},{"issue":"2","key":"10.1016\/j.jval.2020.05.013_bib27","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.2517-6161.1969.tb00796.x","article-title":"Tests for specification errors in classical linear least-squares regression analysis","volume":"31","author":"Ramsey","year":"1969","journal-title":"J\u00a0Royal Stat Soc"},{"issue":"1","key":"10.1016\/j.jval.2020.05.013_bib28","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1146\/annurev-publhealth-040617-013517","article-title":"Modeling health care expenditures and use","volume":"39","author":"Deb","year":"2018","journal-title":"Annual Rev of Pub Health"},{"key":"10.1016\/j.jval.2020.05.013_bib29","series-title":"Models for Health Care","author":"Jones","year":"2011"},{"key":"10.1016\/j.jval.2020.05.013_bib30","series-title":"Health Econometrics Using Stata","author":"Deb","year":"2017"},{"key":"10.1016\/j.jval.2020.05.013_bib31","series-title":"NICE guideline [NG101]: Early and locally advanced breast cancer: diagnosis and treatment","year":"2018"},{"key":"10.1016\/j.jval.2020.05.013_bib32","series-title":"Advanced Breast Cancer: Diagnosis and Treatment","year":"2009"},{"key":"10.1016\/j.jval.2020.05.013_bib33","series-title":"Policy Paper Confirmation of Payment by Results (PbR) Arrangements for 2011-12","year":"2011"},{"issue":"8","key":"10.1016\/j.jval.2020.05.013_bib34","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/hec.966","article-title":"The analysis of incomplete cost data due to dropout","volume":"14","author":"Oostenbrink","year":"2005","journal-title":"Health Econ"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301520321239?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301520321239?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T01:20:29Z","timestamp":1761096029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301520321239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S1098301520321239"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2020.05.013","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Costs of Early Invasive Breast Cancer in England Using National Patient-Level Data","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2020.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 ISPOR-The Professional Society for Health Economics and Outcomes Research. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}